Jefferies raises Fidelis Insurance target to $20, maintains hold

Published 2024-11-15, 01:16 p/m
FIHL
-

On Friday, Jefferies updated its stance on Fidelis Insurance Holdings (NYSE:FIHL), boosting the price target to $20.00 from the previous $19.00, while reiterating a Hold rating on the stock. The firm noted management's positive outlook on growth opportunities in the reinsurance sector due to stable market conditions and the recent Euclid partnership. However, there was a noted decrease in interest for the Specialty's Aviation and Property Direct & Facultative (Prop D&F) lines.

The year-to-date (YTD) and last twelve months (LTM) combined ratio (CR) for Fidelis Insurance has reportedly aligned with the company's mid-to-upper 80s target. This performance has been significantly aided by prior year development (PYD). Jefferies attributes the increase in their earnings per share (EPS) estimates largely to the company's share buyback program and net investment income (NII).

The firm's analysis indicates that the revised price target, which represents a modest increase, reflects a 4% expected total return (ETR). The assessment of Fidelis Insurance's financials points towards a stable outlook for the company, with specific attention to the factors driving the hold recommendation.

The report by Jefferies emphasizes the influence of strategic partnerships and market dynamics on Fidelis Insurance's growth prospects. It also highlights the company's prudent capital management strategies, such as share repurchases, as key contributors to the improved earnings outlook.

In other recent news, Fidelis Insurance Group reported a robust performance in their Q3 earnings call. The company announced a 25% increase in gross premiums written, totaling $742 million, and projected a 20% premium growth for the full year. Fidelis's new Lloyd's Syndicate 3123 is fostering new business opportunities, and with an operating net income of $105 million, or $0.92 per diluted share, the company has returned value to shareholders, including a new $200 million share repurchase authorization.

Fidelis also anticipates manageable losses from Hurricane Milton, with estimated pre-tax losses between $50 million and $100 million. The company maintains a strong market outlook with significant year-on-year pricing adjustments. A strategic partnership with Euclid Mortgage is projected to generate $35 million in gross premiums in 2025.

Some pressure is noted in marine and aviation sectors, and the acquisition ratio has increased due to higher variable commissions in the specialty segment. However, Fidelis's new Lloyd's Syndicate 3123 is seen as a key driver for new business opportunities. The company has repurchased 6.6 million shares at an average price of $16.06, indicating strong capital management, and the fully diluted share count at the end of the quarter was 111,726,363.

InvestingPro Insights

Recent data from InvestingPro sheds additional light on Fidelis Insurance Holdings' (NYSE:FIHL) financial position and market performance. The company's market capitalization stands at $2.2 billion, with a notably low P/E ratio of 5.03, suggesting potential undervaluation relative to earnings. This aligns with one of the InvestingPro Tips, which indicates that FIHL is "trading at a low earnings multiple."

Despite Jefferies' modest price target increase, InvestingPro data shows that FIHL has experienced significant price appreciation, with a year-to-date total return of 58.47% and a one-year total return of 44.55%. This strong performance has brought the stock price to 91.84% of its 52-week high, reflecting investor confidence in the company's prospects.

Another relevant InvestingPro Tip notes that FIHL's "valuation implies a strong free cash flow yield," which could be attractive to value-oriented investors. However, it's worth noting that analysts anticipate a sales decline in the current year, which may explain Jefferies' cautious Hold rating.

For readers interested in a more comprehensive analysis, InvestingPro offers 8 additional tips for FIHL, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.